๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Androgen receptor footprint on the way to prostate cancer progression

โœ Scribed by Myles C. Hodgson, Wayne A. Bowden, Irina U. Agoulnik


Book ID
113035707
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
281 KB
Volume
30
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Androgen receptor: A key molecule in the
โœ Mary-Ellen Taplin; Steven P. Balk ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

Interaction of IGF signaling and the and
โœ Jennifer D. Wu; Kathy Haugk; Libby Woodke; Peter Nelson; Ilsa Coleman; Stephen R ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 352 KB ๐Ÿ‘ 2 views

## Abstract The insulinโ€like growth factor type I receptor (IGFโ€IR) has been suggested to play an important role in prostate cancer progression and possibly in the progression to androgenโ€independent (AI) disease. The term AI may not be entirely correct, in that recent data suggest that expression

Nadir prostate-specific antigen best pre
โœ Juan Morote; Enrique Trilla; Salvador Esquena; Josรฉ Marรญa Abascal; Jaume Revento ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 664 KB

## Abstract The objective of our study was to analyze the value of prostateโ€specific antigen (PSA) levels before and after androgen suppression to predict the time to androgenโ€independent progression (AIP) in patients with advanced and metastatic prostate cancer. A series of 283 prostate cancer pat